Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand treatment

.Sanofi has actually brought in a late access to the radioligand party, spending 100 thousand euros ...

F 2G brings up $100M for 2nd try to get brand new antifungal to market

.After F2G's first effort to receive a new course of antifungal to market was actually wrecked due t...

Moderna targets $1.1 B in R&ampD costs cuts, drops 5 programs among profits pressures

.Moderna has actually vowed to reduce R&ampD investing through $1.1 billion through 2027. The select...

Sanofi's $80M bet on Fulcrum dystrophy medicine finishes in period 3 go belly up

.Just four months after Sanofi bet $80 thousand in beforehand cash on Fulcrum Therapies' losmapimod,...

Oncternal equity sinks 60% amid unemployments, trial discontinuations

.Cancer firm Oncternal Therapeutics is folding all its professional trials as well as giving up team...

Roche is actually keeping out chances that its own injectable being overweight prospect could ultimately show 25% fat loss in late-stage trial

.Roche is actually keeping out chances that its own injectable obesity possibility can ultimately de...

Novo Nordisk hails 'impressive' weight-loss result for dual-acting oral drug in early trial

.Novo Nordisk has actually lifted the lid on a period 1 test of its oral amylin and also GLP-1 recep...

AbbVie takes legal action against BeiGene over blood stream cancer cells medicine classified information

.Merely a couple of brief full weeks after succeeding an FDA Fast Track tag for its own investigatio...

Lilly provides one-two punch with 2nd tranche of favorable data on every week the hormone insulin applicant

.Shortly after a beneficial records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based b...

BridgeBio cuts genetics treatment budget as professional data let down

.BridgeBio Pharma is actually slashing its own gene treatment budget and also pulling back from the ...